Skip to main content

Table 3 The mRNA expression of relative nouropeptides in the stomach and hypothalamus of each group

From: XiangshaLiujunzi decoction alleviates the symptoms of functional dyspepsia by regulating brain–gut axis and production of neuropeptides

Part

Groups

Ghrelin

CCK

VIP

Stomach

Control

1.536 ± 0.509

0.981 ± 0.069

1.092 ± 0.244

Model

0.232 ± 0.172*

0.291 ± 0.121*

0.111 ± 0.059*

XSLJZD

1.735 ± 0.747

1.212 ± 0.320

1.127 ± 0.336

Low dose XSLJZD

0.439 ± 0.074

0.428 ± 0.125

0.394 ± 0.139

Domperidone

1.797 ± 0.869

0.637 ± 0.095

0.555 ± 0.417

hypothalamus

Control

0.967 ± 0.172

1.075 ± 0.268

0.871 ± 0.222

Model

4.917 ± 0.239*

2.923 ± 0.640*

2.084 ± 0.442*

XSLJZD

2.646 ± 0.797

2.162 ± 0.511*

0.777 ± 0.295

Low dose XSLJZD

2.804 ± 0.407

0.916 ± 0.281

1.268 ± 0.285

Domperidone

1.925 ± 0.448

1.113 ± 0.247

0.617 ± 0.073

  1. *P <0.05 compared with the control group; P <0.05 compared with the model group; ∆∆P <0.01 compared with the model group